Potent Cyclic Tetrapeptide for Lead Detoxification
- 23 March 2021
- journal article
- research article
- Published by Wiley in Angewandte Chemie
- Vol. 133 (22) , 12489-12493
Abstract
Lead (Pb) is a ubiquitous poisonous metal, affecting the health of vast populations worldwide. Medications to treat Pb poisoning suffer from various limitations and are often toxic owing to insufficient metal selectivity. Here, we report a cyclic tetrapeptide that selectively binds Pb and eradicates its toxic effect on the cellular level, with superior potency than state‐of‐the‐art drugs. The Pb‐peptide complex is remarkably strong and was characterized experimentally and computationally. Accompanied by the lack of toxicity and enhanced stability of this peptide, these qualities indicate its merit as a potential remedy for Pb poisoning.Keywords
Funding Information
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (PZ00P2_179818)
- Universität Zürich (Forschungskredit)
- Grantová Agentura České Republiky (20-08772S)
This publication has 35 references indexed in Scilit:
- Heavy metal toxicity: An update of chelating therapeutic strategiesJournal of Trace Elements in Medicine and Biology, 2019
- How Pb 2+ Binds and Modulates Properties of Ca 2+ -Signaling ProteinsInorganic Chemistry, 2018
- Chelator combination as therapeutic strategy in mercury and lead poisoningsCoordination Chemistry Reviews, 2018
- Metal chelators and neurotoxicity: lead, mercury, and arsenicArchives of Toxicology, 2017
- Toxicity, mechanism and health effects of some heavy metalsInterdisciplinary Toxicology, 2014
- Toxicity of lead: a review with recent updatesInterdisciplinary Toxicology, 2012
- Heavy Metal Toxicity and the Environment2012
- Chelation in Metal IntoxicationInternational Journal of Environmental Research and Public Health, 2010
- Lead PoisoningAnnual Review of Medicine, 2004
- Treatment of mercury and lead poisonings with dimercaptosuccinic acid and sodium dimercaptopropanesulfonate. A reviewThe Analyst, 1995